NeuroCytonix Launches Clinical Trial Studying Its NeuroCytotron Protocol for Autism

/PRNewswire-PRWeb/ — NeuroCytonix, Inc., today announced that on May 27, 2024, its subsidiary NeuroCytonix Mexico received a regulatory approval letter from…

Comments

  • No comments yet.
  • Add a comment